Cargando…

Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of 3–5 years after diagnosis with limited treatment options. The aim of this study is to assess the psychometric characteristics of the Short Form 36 Health Status Questionnaire (SF-36) in IPF and to provide dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witt, Sabine, Krauss, Ekaterina, Barbero, María Asunción Nieto, Müller, Veronika, Bonniaud, Philippe, Vancheri, Carlo, Wells, Athol U., Vasakova, Martina, Pesci, Alberto, Klepetko, Walter, Seeger, Werner, Crestani, Bruno, Leidl, Reiner, Holle, Rolf, Schwarzkopf, Larissa, Guenther, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397447/ https://www.ncbi.nlm.nih.gov/pubmed/30823880 http://dx.doi.org/10.1186/s12931-019-1010-5

Ejemplares similares

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
por: Guenther, Andreas, et al.
Publicado: (2018)

Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2013)

Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertension
por: Twiss, James, et al.
Publicado: (2013)

Psychometric Evaluation of the SF-36(®) Health Survey in Medicare Managed Care
por: Gandek, Barbara, et al.
Publicado: (2004)

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2012)

Psychometric Evaluation of the Brunei-Malay SF-36 version 2 Health Survey
por: Alhaji, Mohammed M, et al.
Publicado: (2018)

Validation of the SF-36 in patients with endometriosis
por: Stull, Donald E., et al.
Publicado: (2013)

Evaluation of the psychometric properties of the SF-36 health survey for use among Turkish and Moroccan ethnic minority populations in the Netherlands
por: Hoopman, Rianne, et al.
Publicado: (2009)

The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data
por: Huber, Manuel B., et al.
Publicado: (2020)

Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life
por: Huber, Manuel B., et al.
Publicado: (2021)

Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity
por: Wee, Christina C, et al.
Publicado: (2008)

Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data
por: Stöber, Alisa, et al.
Publicado: (2023)

Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples
por: White, Michelle K, et al.
Publicado: (2017)

Psychometric validation of a Saudi Arabian version of the sf-36v2 health survey and norm data for Saudi Arabia
por: AboAbat, Ahmad, et al.
Publicado: (2020)

The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data
por: Witt, Sabine, et al.
Publicado: (2014)

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study
por: Kirsch, Florian, et al.
Publicado: (2019)

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)
por: Palao-Ocharan, Paola, et al.
Publicado: (2022)

Factors Influencing Disabled Stroke Survivors’ Quality of Life in Rural China: Based on the Structural Characteristics and Psychometric Properties of the SF-36 Assessment
por: Xu, Qi, et al.
Publicado: (2023)

SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements
por: van der Meulen, Merel, et al.
Publicado: (2020)

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
por: Stöber, Alisa, et al.
Publicado: (2021)

Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population
por: Demiral, Yucel, et al.
Publicado: (2006)

Measurement equivalence of the SF-36 in the canadian multicentre osteoporosis study
por: Lix, Lisa M, et al.
Publicado: (2012)

Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
por: Pickard, A Simon, et al.
Publicado: (2005)

Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1
por: Farivar, Sepideh S, et al.
Publicado: (2007)

Effects of Nursing Home Residency on Diabetes Care in Individuals with Dementia: An Explorative Analysis Based on German Claims Data
por: Schwarzkopf, Larissa, et al.
Publicado: (2017)

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L
por: Szentes, Boglárka Lilla, et al.
Publicado: (2018)

The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12
por: Hoffman, D L, et al.
Publicado: (2008)

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review
por: Contopoulos-Ioannidis, Despina G, et al.
Publicado: (2009)

Convergent validity between SF-36 and WHOQOL-BREF in older adults
por: Castro, Paula Costa, et al.
Publicado: (2014)

International SF-36 reference values in patients with ischemic heart disease
por: Huber, Alexandra, et al.
Publicado: (2016)

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
por: Strijbis, Eva MM, et al.
Publicado: (2022)

Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data
por: Aljutaili, Majed, et al.
Publicado: (2014)

Reliability, validity, and sensitivity of short-form 36 health survey (SF-36) in patients with sick sinus syndrome
por: Wu, Qiaomin, et al.
Publicado: (2023)

Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery
por: Busija, Lucy, et al.
Publicado: (2008)

Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease
por: Shahriar, Jim, et al.
Publicado: (2003)

Measurement Comparisons of the Medical Outcomes Study and Veterans SF-36(®) Health Survey
por: Kazis, Lewis E., et al.
Publicado: (2004)

Rasch validation of the SF-36 for assessing the health status of Korean older adults
por: Kim, Sae-Hyung, et al.
Publicado: (2015)

Quality of Life in Mexican Older Adults: Factor Structure of the SF-36 Questionnaire
por: Aguirre, Susana Ivonne, et al.
Publicado: (2022)

Establishment of MOS-SF36 percentile ranks in the general youth French population
por: Trognon, Arthur, et al.
Publicado: (2022)

Health Care Service Utilization of Dementia Patients before and after Institutionalization: A Claims Data Analysis
por: Schwarzkopf, Larissa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nfdlh9mjcs1vl4cl06jvcjei4k